Abcellera Biologics Inc (ABCL)

Abcellera Biologics Inc (ABCL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.8B; returns 1 day +4.0%, 1 week +0.2%, 1 year +107.0%.

Abcellera Biologics Inc. (ABCL) is a clinical-stage biotechnology company that leverages a full-stack, AI-powered antibody discovery platform to identify and develop antibody-based medicines.

Groups ABCL belongs to

• Biotechnology
• Canada Companies
• Antibody Therapeutics
• Drug Discovery
• Artificial Intelligence
• Life Sciences
• Clinical Stage Biotech
• Biopharmaceutical
• Strategic Pivot
• Canada
• Healthcare Technology
• Healthcare Innovation

ABCL financial model: income statement, cash flow and balance sheet